The Effect of Hypermobility Healthy Individuals

Overview

Benign Joint Hypermobility Syndrome is a hereditary connective tissue problem characterized by the emergence of multiple musculoskeletal problems in hypermobile individuals without a systemic rheumatologic disease. Studies have shown that hypermobility may also affect lung function. Playing wind instruments requires tiring breathing activity. The effect of wind instrument on lung function and how it affects lung function is a highly controversial issue. Given the distribution and importance of collagen tissue in the body, multiple effects of hypermobility are inevitable. The aim of this study was to evaluate the presence of hypermobility in young healthy individuals; The aim of the study is to investigate the effects of hypermobility on the cardiovascular system and to provide training to the participants regarding the findings.The aim of this study is to investigate the relationship of hypermobility with respiratory functions in professional hypermobile musicians and to compare this relationship with healthy hypermobile individuals who are not engaged in music.

Full Title of Study: “The Effect of Hypermobility on Respiratory Functions in Musicians Playing Wind Instruments and Healthy Individuals Not Involved in Music”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Other
  • Study Primary Completion Date: December 30, 2020

Detailed Description

Sociodemographic data and musical backgrounds of all cases will be recorded. In accordance with the objectives, erm Upper Extremity Hypermobility Assessment Questionnaire "was used for hypermobility, pulmonary function test, respiratory and oral pressure measurement and respiratory muscle strength. The George Respiratory Questionnaire (SGRQ) will be used to assess the quality of life associated with respiration and the risk of asthma with the ile European Respiratory Health Survey, Phase 1 "questionnaire.We believe that the effects of hypermobility on pulmonary functions in healthy individuals will be clarified if this study takes place.

Interventions

  • Other: Respiratory evaluation
    • Hypermobility and Respiratory evaluation

Arms, Groups and Cohorts

  • Healthy Musician
    • At least 15 hypermobile musicians and at least 15 non-hypermobile musicians will be included in the study.
  • Healthy Individuals
    • The study will include at least 15 healthy non-hypermobile individuals who do not deal with music and at least 15 healthy hypermobile individuals who do not deal with music.

Clinical Trial Outcome Measures

Primary Measures

  • The Upper Limb Hypermobility Assessment Tool
    • Time Frame: 10 minutes
    • Hypermobility
  • St. George Respiratory Questionnaire
    • Time Frame: 5 minutes
    • respiratory quality
  • European Respiratory Health Survey, Phase 1
    • Time Frame: 5 minutes
    • assess the risk of asthma
  • Respiratory function test
    • Time Frame: 15minutes
    • FEV1,FVC
  • mouth pressure measurement
    • Time Frame: 15minutes
    • MIP, MEP

Secondary Measures

  • Musculoskeletal Pain Intensity and Interference Questionnaire for Musicians
    • Time Frame: 10 minutes
    • Pain

Participating in This Clinical Trial

Inclusion Criteria for Musicians Be between 18-35 years Playing wind instruments for at least one year For the hypermobile subgroup; Obtaining ≥7 / 12 points from the Upper Extremity Hypermobility Assessment Questionnaire Inclusion Criteria for Healthy Individuals Not Engaged in Music Be between 18-35 years No diagnosed health problems For the hypermobile subgroup; Obtaining ≥7 / 12 points from the Upper Extremity Hypermobility Assessment Questionnaire Exclusion Criteria for Musicians Having a specific respiratory problem diagnosed Symptoms of nerve impingement in upper extremity Smoking Exclusion Criteria for Healthy Individuals Not Engaged in Music Symptoms of nerve impingement in upper extremity Smoking

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 35 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Istanbul Kültür University
  • Collaborator
    • Saglik Bilimleri Universitesi
  • Provider of Information About this Clinical Study
    • Principal Investigator: Gülşah Karaca, Research Assistant – Istanbul Kültür University
  • Overall Official(s)
    • Esra Pehlivan, Asst.Prof.Dr, Principal Investigator, Saglik Bilimleri Universitesi
    • Gulsah Karaca, Researcher, Principal Investigator, Istanbul Kültür University
  • Overall Contact(s)
    • Karaca, 05468744530, karacagulsah92@gmail.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.